NYSE$CLW

Clearwater Paper Corporation · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Clearwater Paper reported a net loss of $52 million and adjusted EBITDA of $15 million.

Clearwater Paper reported a net loss of $52 million, or $3.10 per diluted share, compared to net income of $23 million, or $1.36 per diluted share, for the second quarter of 2020. Adjusted EBITDA for the quarter was $15 million, compared to $79 million in the second quarter of 2020. The company successfully completed planned major maintenance at the Lewiston, Idaho facility and announced the closure of the Neenah, Wisconsin tissue facility.

  • Net loss of $52 million, or $3.10 per diluted share
  • Adjusted EBITDA of $15 million
  • Successfully completed planned major maintenance at the Lewiston, Idaho facility ($22 million Adjusted EBITDA impact)
  • Announced closure of Neenah, Wisconsin tissue facility

Headline financials

Total Revenue

$406M

Previous: $481M-15.5%
EPS (adj)

-$1.07

Previous: $1.67-164.1%
Adjusted EBITDA

$15M

Previous: $79M-81.0%
Paperboard Avg Net Selling Price per ton

$1.06K

Previous: $984.00+7.5%
Capital Expenditures

$10M

Previous: -$7.3M+237.0%
Free Cash Flow

$4.3M

Previous: $15.5M-72.3%
Net Income

-$52M

Previous: $22.8M-328.1%
Operating Income

-$56.6M

Previous: $48.1M-217.7%
Gross Profit

$14.2M

Previous: $83.8M-83.1%
Cash & Equivalents

$60.9M

Previous: $48.2M+26.3%
Total Assets

$1.75B

Previous: $1.84B-4.9%
Stock-Based Comp

$700K

Previous: $3.3M-78.8%

Revenue & EPS history

Clearwater Paper · Revenue · Quarterly

$406M

Q2 2021-15.5%vs Q2 2020
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Forward guidance

Clearwater Paper expects strong cash flows and further net debt reduction in the latter half of 2021. The paperboard business continues to perform well, and tissue demand is recovering.

Tailwinds

  • Well positioned to realize strong cash flows in the latter half of 2021
  • Further reduce net debt in the latter half of 2021
  • Paperboard business continues to perform well with favorable market dynamics
  • Tissue demand is continuing to recover after a retailer and consumer drawdown of inventory
  • Focus on operational execution

Headwinds

  • Working to offset inflation across our business
  • Closing our high cost Neenah tissue facility
  • Consumers de-stocked pantries
  • Retailers adjusted inventories
  • Mitigate pulp price inflation

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-2.7%

Avg return

Earnings day

-4.4%

Avg return

5 days after

-4.0%

Avg return

30 days after

39%

26 / 66 earnings

Positive

+24.1%

Q1 2022

Best reaction

-33.5%

Q1 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-13.5%-14.3%+9.8%
Q4 2025-8.6%-15.1%-26.6%
Q3 2025-8.5%-6.2%-5.8%
Q2 2025-18.4%-24.9%-26.7%
Q1 2025+7.4%+4.0%+15.1%
Q4 2024-8.4%-3.9%-17.6%
Q3 2024+8.3%+4.8%+5.0%
Q2 2024-23.3%-34.5%-39.1%
Q1 2024+12.0%+12.4%+30.3%
Q4 2023+3.4%+7.5%+21.7%
Q3 2023-2.1%+3.1%+1.2%
Q2 2023+14.8%+10.9%+18.8%
Q1 2023-15.9%-12.2%-18.7%
Q4 2022-0.2%-1.0%-10.8%
Q3 2022-15.1%-10.4%-10.4%
Q2 2022+15.3%+20.1%+18.4%
Q1 2022+24.1%+20.8%+28.6%
Q4 2021-12.7%-7.4%-6.0%
Q3 2021+0.4%-6.5%+0.5%
Q2 2021+2.1%+8.4%+18.5%
Q1 2021-10.0%-14.0%-16.4%
Q4 2020-18.7%-15.1%-11.4%
Q3 2020-12.2%-13.2%-8.0%
Q2 2020+2.5%-4.7%-14.1%
Q1 2020+21.2%+21.5%+36.5%
Q4 2019+10.2%+11.2%-18.5%
Q3 2019+2.2%-0.4%+6.1%
Q2 2019-13.9%-0.3%-18.5%
Q1 2019-10.7%-3.7%-20.1%
Q4 2018-16.0%-17.0%-25.4%
Q3 2018-6.6%-6.3%-0.9%
Q2 2018+11.9%+14.8%+28.5%
Q1 2018-33.5%-40.3%-35.8%
Q4 2017-25.1%-23.0%-13.8%
Q3 2017+3.2%+4.5%+4.0%
Q2 2017-9.2%-9.0%-6.6%
Q1 2017-13.4%-12.6%-18.8%
Q4 2016-6.7%-3.9%-17.3%
Q3 2016-14.7%-15.3%-3.7%
Q2 2016-7.1%-5.4%-11.0%
Q1 2016+10.1%
Q4 2015-5.9%
Q3 2015+1.2%
Q2 2015+10.2%
Q1 2015+1.8%
Q4 2014-17.4%
Q3 2014+0.4%
Q2 2014+12.0%
Q1 2014-1.4%
Q4 2013+9.6%
Q3 2013+8.3%
Q2 2013-0.7%
Q1 2013-8.6%
Q4 2012+4.3%
Q3 2012-6.6%
Q2 2012+4.9%
Q1 2011-0.9%
Q1 2012+7.2%
Q4 2009-0.4%
Q1 2010-0.4%
Q4 2011-0.4%
Q3 2011-1.8%
Q3 2010-1.8%
Q2 2010-5.2%
Q4 2010-5.2%
Q2 2011-5.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro